tranexamic acid has been researched along with Hemoptysis in 45 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Hemoptysis: Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TA) is used to control bleeding in patients with hemoptysis." | 9.69 | Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial. ( Aggarwal, P; Bhoi, S; Ekka, M; Gopinath, B; Jamshed, N; Kappagantu, V; Kumar, A; Mishra, PR; Naik, SR; Nayaka, R; Ramaswami, A; Shrimal, P; Sinha, TP, 2023) |
| "This randomized double blinded placebo controlled trial could not demonstrate the benefit of tranexamic acid in shortening the days of hemoptysis and confirm the low incidence of side effects of this drug." | 9.10 | Tranexamic acid in patients with hemoptysis. ( Chvaychoo, B; Maranetra, N; Naruman, C; Tscheikuna, J, 2002) |
| "In hospitalized patients with hemoptysis, the risk of VTE was found to be independently associated with the administration of tranexamic acid (TXA), the presence of D-dimer, and the Charlson Comorbidity Index (CCI) score (p<0." | 8.31 | Does the use of tranexamic acid increase the risk of VTE in patients with hemoptysis? ( Dong, YY; Fang, SY; Zhang, JL, 2023) |
| " We describe a case of a patient supported by a right ventricular assist device with an oxygenator and a left ventricular assist device who developed pulmonary hemorrhage that was successfully treated with nebulized tranexamic acid (TXA)." | 8.12 | Inhaled Tranexamic Acid for the Management of Hemoptysis in a Patient With Right and Left Ventricular Assist Devices: A Case Report. ( Angelidis, IK; Budd, AN; Malsin, ES; Patel, S; Pawale, A; Smith, S, 2022) |
| "While most previous studies have viewed tranexamic acid as a bridging or temporary therapy, our preliminary study offers insights into the combined therapy of antifibrinolytic agent with endovascular treatment for hemoptysis." | 8.02 | Combined therapy with bronchial artery embolization and tranexamic acid for hemoptysis. ( Cho, SK; Hyun, D; Lee, HN; Park, HS; Park, KB; Shin, SW; Soo Do, Y, 2021) |
| "Although tranexamic acid (TXA), a readily accessible antifibrinolytic agent, is widely adopted in hemorrhage scenarios, its role on mortality in patients with hemoptysis remains uncertain." | 8.02 | Does tranexamic acid reduce risk of mortality on patients with hemoptysis?: A protocol for systematic review and meta-analysis. ( Bai, CH; Chang, JH; Chen, LF; Chu, KC; Hsu, CW; Hsu, YP; Lin, TY; Pao, PJ; Wang, TC; Yang, CH, 2021) |
| "Forty-six patients receiving endobronchial ε-aminocaproic acid for the treatment or prevention of pulmonary bleeding." | 7.96 | Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series. ( Oromendia, C; Rajwani, K; Ramos, LG; Sanso, LM; Simon, RP, 2020) |
| "Tranexamic acid (TA) used in a variety of conditions associated with bleeding has been associated with potential thrombotic side effects such as formation of thrombi and pulmonary embolism (PE)." | 7.77 | Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. ( Krivokuca, I; Lammers, JW, 2011) |
| "A 68-year-old man was admitted and received tranexamic acid for persistent hemoptysis." | 7.77 | Generalized convulsion resulted in hyperammonemia during treatment with tranexamic acid for hemoptysis. ( Chen, HC; Chen, SC; Huang, MS; Wang, CS; Yang, CJ, 2011) |
| "Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to control bleeding." | 6.87 | Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. ( Epstein Shochet, G; Guber, A; Guber, E; Israeli-Shani, L; Shitrit, D; Wand, O, 2018) |
| "Hemoptysis and pulmonary embolism (PE) are life-threatening pulmonary emergencies that, when present together, create a therapeutic conundrum." | 5.56 | Nebulized Tranexamic Acid Therapy for Hemoptysis Associated with Submassive Pulmonary Embolism. ( Dhanani, JA; Reade, MC; Roberts, J, 2020) |
| "Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent used to prevent and treat various bleeding complications." | 5.48 | Hemoptysis? Try Inhaled Tranexamic Acid. ( Komura, S; Peabody, CR; Rodriguez, RM, 2018) |
| "Many patients with cancer involving the respiratory system suffer from the frequent recurrence of significant, submassive hemoptysis, which may result in invasive procedures, hospital stays, and a reduction in quality of life." | 5.42 | Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis. ( Hankerson, MJ; Mallon, WK; Raffetto, B; Shoenberger, JM, 2015) |
| "Major hemoptysis is a potentially life-threatening complication of cystic fibrosis (CF) lung disease." | 5.31 | Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. ( Graff, GR, 2001) |
| "Hemoptysis was only partially controlled by repeated bronchial arterial embolizations." | 5.29 | Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid. ( Culham, G; Davidson, AG; DeJong, BP; Lillquist, YP; Wong, LT, 1996) |
| "In hospitalized patients with hemoptysis, the risk of VTE was found to be independently associated with the administration of tranexamic acid (TXA), the presence of D-dimer, and the Charlson Comorbidity Index (CCI) score (p<0." | 4.31 | Does the use of tranexamic acid increase the risk of VTE in patients with hemoptysis? ( Dong, YY; Fang, SY; Zhang, JL, 2023) |
| " We describe a case of a patient supported by a right ventricular assist device with an oxygenator and a left ventricular assist device who developed pulmonary hemorrhage that was successfully treated with nebulized tranexamic acid (TXA)." | 4.12 | Inhaled Tranexamic Acid for the Management of Hemoptysis in a Patient With Right and Left Ventricular Assist Devices: A Case Report. ( Angelidis, IK; Budd, AN; Malsin, ES; Patel, S; Pawale, A; Smith, S, 2022) |
| "Forty-six patients receiving endobronchial ε-aminocaproic acid for the treatment or prevention of pulmonary bleeding." | 3.96 | Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series. ( Oromendia, C; Rajwani, K; Ramos, LG; Sanso, LM; Simon, RP, 2020) |
| "Tranexamic acid (TA) used in a variety of conditions associated with bleeding has been associated with potential thrombotic side effects such as formation of thrombi and pulmonary embolism (PE)." | 3.77 | Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. ( Krivokuca, I; Lammers, JW, 2011) |
| "A 68-year-old man was admitted and received tranexamic acid for persistent hemoptysis." | 3.77 | Generalized convulsion resulted in hyperammonemia during treatment with tranexamic acid for hemoptysis. ( Chen, HC; Chen, SC; Huang, MS; Wang, CS; Yang, CJ, 2011) |
| "Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to control bleeding." | 2.87 | Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. ( Epstein Shochet, G; Guber, A; Guber, E; Israeli-Shani, L; Shitrit, D; Wand, O, 2018) |
| " As aetiology of haemoptysis as well as length of treatment, dosage and form of TA administration varied between the studies, strong recommendations are difficult to give." | 2.49 | Does tranexamic acid stop haemoptysis? ( Burrell, A; Dunning, J; Moen, CA, 2013) |
| "Hemoptysis and pulmonary embolism (PE) are life-threatening pulmonary emergencies that, when present together, create a therapeutic conundrum." | 1.56 | Nebulized Tranexamic Acid Therapy for Hemoptysis Associated with Submassive Pulmonary Embolism. ( Dhanani, JA; Reade, MC; Roberts, J, 2020) |
| "Hemoptysis is a major cause of morbidity and mortality in patients with cystic fibrosis (CF)." | 1.51 | Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. ( Al-Samkari, H; Cardoni, L; Connors, JM; McMahon, L; Perkins, R; Pighetti, EH; Rits, S; Shin, K; Uluer, A, 2019) |
| "Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients, which should be managed as invasive aspergillosis." | 1.43 | Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. ( Ader, F; Beigelman-Aubry, C; Blot, S; Cadranel, J; Chakrabarti, A; Denning, DW; Dimopoulos, G; Lange, C; Ullmann, AJ, 2016) |
| "Many patients with cancer involving the respiratory system suffer from the frequent recurrence of significant, submassive hemoptysis, which may result in invasive procedures, hospital stays, and a reduction in quality of life." | 1.42 | Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis. ( Hankerson, MJ; Mallon, WK; Raffetto, B; Shoenberger, JM, 2015) |
| "Treatment with tranexamic acid resolved the haemoptysis." | 1.39 | Treatment of haemoptysis in pulmonary atresia with tranexamic acid. ( Devine, MJ; Radford, DJ, 2013) |
| "Though her hemoptysis improved, respiratory failure suddenly worsened." | 1.33 | [A case of acute exacerbation of chronic pulmonary thromboembolism with essential thrombocythemia during treatment for hemoptysis]. ( Abe, T; Haraguchi, M; Hayashi, M; Ito, K; Nakajima, H; Sakagami, T; Tsutsui, N, 2006) |
| "Major hemoptysis is a potentially life-threatening complication of cystic fibrosis (CF) lung disease." | 1.31 | Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. ( Graff, GR, 2001) |
| "Hemoptysis was only partially controlled by repeated bronchial arterial embolizations." | 1.29 | Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid. ( Culham, G; Davidson, AG; DeJong, BP; Lillquist, YP; Wong, LT, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.44) | 18.7374 |
| 1990's | 3 (6.67) | 18.2507 |
| 2000's | 5 (11.11) | 29.6817 |
| 2010's | 22 (48.89) | 24.3611 |
| 2020's | 13 (28.89) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, S | 1 |
| Angelidis, IK | 1 |
| Malsin, ES | 1 |
| Smith, S | 1 |
| Pawale, A | 1 |
| Budd, AN | 1 |
| Gopinath, B | 3 |
| Mishra, PR | 4 |
| Aggarwal, P | 4 |
| Nayaka, R | 3 |
| Naik, SR | 3 |
| Kappagantu, V | 3 |
| Shrimal, P | 3 |
| Ramaswami, A | 3 |
| Bhoi, S | 3 |
| Jamshed, N | 3 |
| Sinha, TP | 3 |
| Ekka, M | 3 |
| Kumar, A | 3 |
| Chang, J | 1 |
| Ma, KC | 1 |
| Zhang, JL | 1 |
| Dong, YY | 1 |
| Fang, SY | 1 |
| Kinoshita, T | 1 |
| Ohbe, H | 1 |
| Matsui, H | 1 |
| Fushimi, K | 1 |
| Ogura, H | 1 |
| Yasunaga, H | 1 |
| Simon, RP | 1 |
| Oromendia, C | 1 |
| Sanso, LM | 1 |
| Ramos, LG | 1 |
| Rajwani, K | 1 |
| Mervau, J | 1 |
| Jason, S | 1 |
| Jones, JS | 1 |
| Yazici, O | 1 |
| Gulen, ST | 1 |
| Ceylan, E | 1 |
| Gavioli, E | 1 |
| Aung, CC | 1 |
| Lee, HN | 1 |
| Park, HS | 1 |
| Hyun, D | 1 |
| Cho, SK | 1 |
| Park, KB | 1 |
| Shin, SW | 1 |
| Soo Do, Y | 1 |
| Tsai, YS | 1 |
| Hsu, LW | 1 |
| Wu, MS | 1 |
| Chen, KH | 1 |
| Kang, YN | 1 |
| Chen, LF | 1 |
| Wang, TC | 1 |
| Lin, TY | 1 |
| Pao, PJ | 1 |
| Chu, KC | 1 |
| Yang, CH | 1 |
| Chang, JH | 1 |
| Hsu, CW | 1 |
| Bai, CH | 1 |
| Hsu, YP | 1 |
| Komura, S | 1 |
| Rodriguez, RM | 1 |
| Peabody, CR | 1 |
| Wand, O | 3 |
| Guber, E | 3 |
| Guber, A | 3 |
| Epstein Shochet, G | 3 |
| Israeli-Shani, L | 3 |
| Shitrit, D | 3 |
| Al-Samkari, H | 1 |
| Shin, K | 1 |
| Cardoni, L | 1 |
| Pighetti, EH | 1 |
| Rits, S | 1 |
| McMahon, L | 1 |
| Perkins, R | 1 |
| Uluer, A | 1 |
| Connors, JM | 1 |
| Messika, J | 1 |
| Prat, D | 1 |
| Sztrymf, B | 1 |
| Dunn, AS | 1 |
| Dhanani, JA | 1 |
| Roberts, J | 1 |
| Reade, MC | 1 |
| Bharath, G | 1 |
| Adams, TR | 1 |
| Reeder, JA | 1 |
| Alqassab, F | 1 |
| Gilbert, BW | 1 |
| Alberto-Pasco, C | 1 |
| Soto, A | 1 |
| Moen, CA | 1 |
| Burrell, A | 1 |
| Dunning, J | 1 |
| Haghi, M | 1 |
| van den Oetelaar, W | 1 |
| Moir, LM | 1 |
| Zhu, B | 1 |
| Phillips, G | 1 |
| Crapper, J | 1 |
| Young, PM | 1 |
| Traini, D | 1 |
| Hankerson, MJ | 1 |
| Raffetto, B | 1 |
| Mallon, WK | 1 |
| Shoenberger, JM | 1 |
| Denning, DW | 1 |
| Cadranel, J | 1 |
| Beigelman-Aubry, C | 1 |
| Ader, F | 1 |
| Chakrabarti, A | 1 |
| Blot, S | 1 |
| Ullmann, AJ | 1 |
| Dimopoulos, G | 1 |
| Lange, C | 1 |
| Segrelles Calvo, G | 1 |
| De Granda-Orive, I | 1 |
| López Padilla, D | 1 |
| Bellam, BL | 1 |
| Dhibar, DP | 1 |
| Suri, V | 1 |
| Sharma, N | 1 |
| Varma, SC | 1 |
| Malhotra, S | 1 |
| Bhalla, A | 1 |
| Prutsky, G | 2 |
| Domecq, JP | 2 |
| Salazar, CA | 2 |
| Accinelli, R | 2 |
| Solomonov, A | 1 |
| Fruchter, O | 1 |
| Zuckerman, T | 1 |
| Brenner, B | 1 |
| Yigla, M | 1 |
| Krivokuca, I | 1 |
| Lammers, JW | 1 |
| Wang, CS | 1 |
| Yang, CJ | 1 |
| Chen, SC | 1 |
| Chen, HC | 1 |
| Huang, MS | 1 |
| Hurley, M | 1 |
| Bhatt, J | 1 |
| Smyth, A | 1 |
| Devine, MJ | 1 |
| Radford, DJ | 1 |
| Tscheikuna, J | 1 |
| Chvaychoo, B | 1 |
| Naruman, C | 1 |
| Maranetra, N | 1 |
| Ghosh, AK | 1 |
| Smithson, SF | 1 |
| Mumford, A | 1 |
| Patteril, M | 1 |
| Amer, K | 1 |
| Abe, T | 1 |
| Hayashi, M | 1 |
| Sakagami, T | 1 |
| Tsutsui, N | 1 |
| Ito, K | 1 |
| Nakajima, H | 1 |
| Haraguchi, M | 1 |
| Müller-Wening, D | 1 |
| Karg, O | 1 |
| Blaha, H | 1 |
| Wong, LT | 1 |
| Lillquist, YP | 1 |
| Culham, G | 1 |
| DeJong, BP | 1 |
| Davidson, AG | 1 |
| Chang, AB | 1 |
| Ditchfield, M | 1 |
| Robinson, PJ | 1 |
| Robertson, CF | 1 |
| Carbone, R | 1 |
| Dessanti, P | 1 |
| Sblendorio, L | 1 |
| Graff, GR | 1 |
| Houwing, RH | 1 |
| Leguit, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-08-01 | Not yet recruiting | ||
| [NCT01496196] | Phase 3 | 100 participants (Anticipated) | Interventional | 2012-01-31 | Recruiting | ||
| Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA) in Chinese Patients -Multicenter Study[NCT03027089] | 560 participants (Anticipated) | Observational | 2017-01-31 | Recruiting | |||
| Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)[NCT03126968] | Phase 2/Phase 3 | 100 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for tranexamic acid and Hemoptysis
| Article | Year |
|---|---|
Effects of Tranexamic Acid on Hemoptysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Randomized Controlled Trials as Topic; Tranexamic Acid | 2020 |
Does tranexamic acid stop haemoptysis?
Topics: Antifibrinolytic Agents; Benchmarking; Evidence-Based Medicine; Hemoptysis; Humans; Patient Selectio | 2013 |
Antifibrinolytic therapy to reduce haemoptysis from any cause.
Topics: Administration, Oral; Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Injections, Intravenous; P | 2016 |
Antifibrinolytic therapy to reduce haemoptysis from any cause.
Topics: Administration, Oral; Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Injections, Intravenous; P | 2012 |
4 trials available for tranexamic acid and Hemoptysis
| Article | Year |
|---|---|
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Patient Discharge; Pilot Projects; Tranexamic Ac | 2023 |
Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Monitoring; Fe | 2018 |
Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Monitoring; Fe | 2018 |
Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Monitoring; Fe | 2018 |
Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Monitoring; Fe | 2018 |
Efficacy of tranexamic acid in haemoptysis: A randomized, controlled pilot study.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemoptysis; Hospitalization; Humans; Infu | 2016 |
Tranexamic acid in patients with hemoptysis.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Female; Hemoptysis; Humans; Male; Middle Aged; | 2002 |
37 other studies available for tranexamic acid and Hemoptysis
| Article | Year |
|---|---|
Inhaled Tranexamic Acid for the Management of Hemoptysis in a Patient With Right and Left Ventricular Assist Devices: A Case Report.
Topics: Anticoagulants; Heart-Assist Devices; Hemoptysis; Hemorrhage; Humans; Shock, Cardiogenic; Tranexamic | 2022 |
Tranexamic Acid in the Treatment Paradigm for Hemoptysis.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Tranexamic Acid; Treatment Outcome | 2023 |
Does the use of tranexamic acid increase the risk of VTE in patients with hemoptysis?
Topics: Hemoptysis; Humans; Patients; Risk Factors; Tranexamic Acid; Venous Thromboembolism | 2023 |
Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study.
Topics: Aged; Antifibrinolytic Agents; Female; Hemoptysis; Hospital Mortality; Humans; Japan; Male; Middle A | 2019 |
Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Bronchoscopy; Female; Hemoptysis; Hemorrhage; Huma | 2020 |
BET 1: Does inhaled tranexamic acid reduce morbidity in adults with haemoptysis?
Topics: Administration, Inhalation; Adult; Antifibrinolytic Agents; Evidence-Based Emergency Medicine; Hemop | 2020 |
The effect of ankaferd blood stopper used for massive haemoptysis in a patient with mounier-kuhn syndrome: A case report.
Topics: Adult; Antifibrinolytic Agents; Bronchoscopy; Cryotherapy; Epinephrine; Hemoptysis; Hemostasis, Endo | 2020 |
Haemoptysis management in cystic fibrosis: A case report and treatment pathway.
Topics: Antifibrinolytic Agents; Cystic Fibrosis; Embolization, Therapeutic; Hemoptysis; Humans; Male; Middl | 2020 |
Combined therapy with bronchial artery embolization and tranexamic acid for hemoptysis.
Topics: Aged; Bronchial Arteries; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; | 2021 |
Does tranexamic acid reduce risk of mortality on patients with hemoptysis?: A protocol for systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Bleeding Time; Hemoptysis; Hospital Mortality; Humans; Length of Stay; Meta | 2021 |
Hemoptysis? Try Inhaled Tranexamic Acid.
Topics: Aged; Antifibrinolytic Agents; Female; Hemoptysis; Humans; Inhalation; Nebulizers and Vaporizers; Tr | 2018 |
Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Critical Pathways; Cystic Fibrosis; Drug Monitori | 2019 |
Tranexamic Acid Inhalations in Nonmassive Hemoptysis: A Word of Caution.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Tranexamic Acid | 2019 |
Response.
Topics: Hemoptysis; Humans; Tranexamic Acid | 2019 |
Inhaled tranexamic acid improved recovery from hemoptysis compared with placebo.
Topics: Hemoptysis; Humans; Tranexamic Acid | 2019 |
Nebulized Tranexamic Acid Therapy for Hemoptysis Associated with Submassive Pulmonary Embolism.
Topics: Administration, Inhalation; Aged; Anticoagulants; Antifibrinolytic Agents; Hemoptysis; Heparin; Huma | 2020 |
Tranexamic Acid: Emerging Therapies in Hemoptysis.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Tranexamic Acid | 2019 |
Response.
Topics: Hemoptysis; Humans; Tranexamic Acid | 2019 |
Inhaled TXA for cases of massive hemoptysis.
Topics: Antifibrinolytic Agents; Hemoptysis; Hemorrhage; Humans; Tissue Plasminogen Activator; Tranexamic Ac | 2020 |
[Association of tranexamic acid to mortality and blood transfusion among patients with hemoptysis at Hipólito Unanue Hospital of Lima, Peru].
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemoptysis; Hospitals; Humans; Male; Peru | 2013 |
Inhalable tranexamic acid for haemoptysis treatment.
Topics: Administration, Inhalation; Aerosols; Antifibrinolytic Agents; Cell Line; Chemistry, Pharmaceutical; | 2015 |
Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Nebulizers and Vaporizers; Neoplasms; Palliative Care; | 2015 |
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Topics: Antifibrinolytic Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchial Arte | 2016 |
Inhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Antifibrinolytic Agents; Cystic Fibrosis; Hemop | 2016 |
Pulmonary hemorrhage: A novel mode of therapy.
Topics: Adult; Aged; Antifibrinolytic Agents; Bronchi; Female; Hemoptysis; Humans; Male; Middle Aged; Tranex | 2009 |
Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid.
Topics: Antifibrinolytic Agents; Chronic Disease; Female; Hemoptysis; Humans; Middle Aged; Pulmonary Embolis | 2011 |
Generalized convulsion resulted in hyperammonemia during treatment with tranexamic acid for hemoptysis.
Topics: Aged; Antifibrinolytic Agents; Hemoptysis; Humans; Hyperammonemia; Male; Seizures; Tranexamic Acid | 2011 |
Treatment massive haemoptysis in cystic fibrosis with tranexamic acid.
Topics: Adolescent; Cystic Fibrosis; Hemoptysis; Humans; Male; Tranexamic Acid | 2011 |
Treatment of haemoptysis in pulmonary atresia with tranexamic acid.
Topics: Adult; Antifibrinolytic Agents; Blalock-Taussig Procedure; Female; Heart Septal Defects; Hemoptysis; | 2013 |
Klippel-Trenauney-Weber syndrome associated with hemoptysis.
Topics: Adult; Antifibrinolytic Agents; Hemoptysis; Humans; Klippel-Trenaunay-Weber Syndrome; Male; Tranexam | 2004 |
[A case of acute exacerbation of chronic pulmonary thromboembolism with essential thrombocythemia during treatment for hemoptysis].
Topics: Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Chronic Disease; Female; Hemoptysis; Humans; Ox | 2006 |
[Life-threatening hemoptysis. Diagnosis and therapy].
Topics: Adult; Aged; Aprotinin; Emergencies; Female; Hemoptysis; Humans; Lung Diseases; Male; Middle Aged; P | 1982 |
Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid.
Topics: Antifibrinolytic Agents; Bronchial Arteries; Child; Cystic Fibrosis; Embolization, Therapeutic; Fema | 1996 |
Major hemoptysis in a child with cystic fibrosis from multiple aberrant bronchial arteries treated with tranexamic acid.
Topics: Adolescent; Antifibrinolytic Agents; Bronchial Arteries; Combined Modality Therapy; Cystic Fibrosis; | 1996 |
Idiopathic pulmonary haemosiderosis in an adult.
Topics: Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Hemoptysis; Hemosiderosis; | 1998 |
Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid.
Topics: Adult; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hemoptysis; Hum | 2001 |
[Skin necrosis following administration of vasopressin].
Topics: Aged; Female; Hemoptysis; Humans; Multiple Organ Failure; Necrosis; Skin; Tranexamic Acid; Vasopress | 1987 |